Effect of ATP and molsidomine combination on contractile function of isolated adult and old rat hearts during adequate coronary perfusion, at ischemia and reperfusion
Abstract. Pathology of the cardiovascular system occupies a major place in the structure of diseases of the elderly and old patients. Metabolic disturbances are very important in ischemic damages of myocardium in the elderly and old people. So, drugі with metabolic mechanism of action is very ppromising in the treatment of elderly patients with cardiovascular diseases. The relevance of this study is determined by the feasibility of using drugs of metabolic action, which have a beneficial effect on the metabolism of cardiomyocytes, improve blood supply to the myocardium, increase its contractile function. The effect of ATP-molsidomine combination on myocardial contractility in different age animals was stuiesy in vitro experiments. The experiments on the isolated hearts from adult and old rats have shown that combined use of ATP and molsidomine did not significantly affect the contractility of the isolated hearts of adult rats under different perfusion regimes. In old rats, the use of ATP-molsidomine combination had a positive effect on the contractile function of the myocardium under the influence of damaging factors (ischemia, reperfusion): prevented a decrease of left ventricular developing pressure and its first derivative (velocity of pressure rise and velocity of pressure decline) and accelerated its growth during reperfusion. Co-administration of ATP and molsidomine during ischemia had a positive effect on the heart rhythm and restored heart rate at the reperfusion period in adult and old rats. The results of the study indicate a positive effect of the ATP-molsidomine combination on the myocardial contractility in old rats. Combined use of ATP and molsidomine exerted a favourable influence on the heart rhythm under damaging factors both in the adult and old animals.
Kosarev, V. V.; Babanov, S. A. Pharmacotherapy of ischemic heart disease: cytoprotectors in focus. Russian medical journal 2011, 19, 2, рр. 1-4. (in Russian)
Mikhin, V. P. Cytoprotection in cardiology: progress and prospects. Cardiology 2015, 10, рр. 22-28. https://doi.org/10.20514/2226-6704-2014-0-1-44-49 (in Russian)
Amosova, K. M.; Bereza, N. V. Influence of complex treatment with inclusion of ATP-long on indicators of contractile ability of a myocardium at patients with coronary heart disease at rest and at isometric loading. Galician Medical Bulletin 2001, 8, 4, рр. 10-12. (in Ukrainian)
Amosova, E. N.; Bereza, N. V.; Potapkova, I. V. The effect of complex therapy with the inclusion of ATP-long on the diastolic function of the left ventricle in patients with coronary heart disease at rest and with isometric exercise. Medicine 2002, 3-4, рр. 48-51. (in Russian)
Fukunaga, A. F.; Flacke, W. E.; Bloor, B. C. Hypotensive effects of adenosine triphosphate compared with sodium nitroprusside. Anesth. Analg. 1982, 61, 3, pp. 273-278. https://doi.org/10.11213/00000539-198203000-00010
Hoka, S.; Takeshita, A.; Aishima, K. et al. Vasodilator effects of adenosine triphosphate and sodium nitroprusside: comparisons during controlled hypotension. J. Anesth. 1987, 1, 2, pp. 143-147. https://doi.org/10.1007/s0054070010143
Chistik, T. Donators of nitric oxide in the treatment of cardiovascular pathology: nitrates or sydnoneimines? News of medicine and pharmacy 2014, 1-2, рр. 485-486. (in Russian) https://doi.org/10.22141/2224-1422.214.171.1248.131062.
Fallen, E. L.; Elliot, W. C.; Gorlin, R. Apparatus for study of ventricular function and metabolism in isolated perfused rat heart. J. Appl. Physiol. 1967, 22 (4), рр. 836-839.
Zhigunova, A. K. Cardioprotective drug ATP-long and its effect on metabolic processes in the myocardium. Ukr. Med. Bulletin 2012, 3, p 89. (in Russian)
Eltzschig, H. K. Adenosine: an old drug newly discovered. Anesthesiology 2009, 11, 4, рр. 904-915. https://doi.org/ 10.1097/ALN.0b013e3181b060f2
Vertkin, A. L.; Topolyansky, A. V. Molsidomin - new perspectives. Russian medical 2005, 7, рр. 430-435. (in Russian) http://dx.doi.org/10.22141/2224-14126.96.36.1998.131062
Arkonas, B. M.; Kersten, J. R.; Wynsen, J. C. et al. Differential hemodynamic effects of the nitric oxide donor pirsidomine in comparison to SIN-1, nitroprusside, and nitroglycerin. Pharmacology 1996, 52, pp. 92-100 https://doi.org/10.1159/000139372